# Elutia outlines NXT-41X FDA submission this quarter, targeting Q2 2027 clearance

- Source: Seeking Alpha Market Currents
- Published: 2026-11-06T16:46:10+00:00
- Category: Markets
- Original: https://seekingalpha.com/news/4668357-elutia-outlines-nxtminus-41x-fda-submission-this-quarter-targeting-q2-2027-clearance?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
- Canonical: https://groundlevelnews.com/story/elutia-outlines-nxt-41x-fda-submission-this-quarter-targeting-q2-2027--2e33c9/

Read the full report from the original publisher.

_Ground Level News shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents._